FOSIPMA, a federation of pharma manufacturers associations in South India, alleges that the decision to ban 344 drugs is baseless
Under NLEM 2011, there were 628 drug formulations that were under the price control which now has been increased to over 800
Q&A with Gerald Heddell, director of inspection, enforcement and standards, MHRA